BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23052195)

  • 1. Neuropeptide Y Y1 receptor knockdown can modify glutathione peroxidase and c-AMP response element-binding protein in phenylpropanolamine-treated rats.
    Hsieh YS; Chen PN; Kuo MH; Kuo DY
    Arch Toxicol; 2013 Mar; 87(3):469-79. PubMed ID: 23052195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knocking down the transcript of protein kinase C-lambda modulates hypothalamic glutathione peroxidase, melanocortin receptor and neuropeptide Y gene expression in amphetamine-treated rats.
    Hsieh YS; Yang SF; Chen PN; Chu SC; Chen CH; Kuo DY
    J Psychopharmacol; 2011 Jul; 25(7):982-94. PubMed ID: 20817751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of neuropeptide Y Y1 receptor in the regulation of amphetamine-mediated appetite suppression.
    Kuo DY; Chen PN; Yu CH; Kuo MH; Hsieh YS; Chu SC
    Neuropharmacology; 2012 Oct; 63(5):842-50. PubMed ID: 22732442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcript of protein kinase A knock-down modulates feeding behavior and neuropeptide Y gene expression in phenylpropanolamine-treated rats.
    Hsieh YS; Yang SF; Chu SC; Kuo DY
    Physiol Genomics; 2007 Oct; 31(2):306-14. PubMed ID: 17684035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The identification of neuropeptide Y receptor subtype involved in phenylpropanolamine-induced increase in oxidative stress and appetite suppression.
    Hsieh YS; Kuo MH; Chen PN; Kuo DY
    Neuromolecular Med; 2013 Mar; 15(1):159-68. PubMed ID: 23179670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting neuropeptide Y Y1 receptor modulates melanocortin receptor- and NF-κB-mediated feeding behavior in phenylpropanolamine-treated rats.
    Hsieh YS; Chen PN; Yu CH; Liao JM; Kuo DY
    Horm Behav; 2013 Jun; 64(1):95-102. PubMed ID: 23707533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of protein kinase Calpha isozyme in the regulation of oxidative stress and neuropeptide Y gene expression in phenylpropanolamine-mediated appetite suppression.
    Kuo DY; Yang SF; Chu SC; Chen CH; Hsieh YS
    J Neurochem; 2009 Mar; 108(6):1495-506. PubMed ID: 19183253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebral administration of protein kinase A or cAMP response element-binding protein antisense oligonucleotide can modulate amphetamine-mediated appetite suppression in free-moving rats.
    Hsieh YS; Yang SF; Kuo DY
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E123-31. PubMed ID: 16896163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of oxidative stress in the regulation of NPY/CART-mediated appetite control in amphetamine-treated rats.
    Hsieh YS; Chen PN; Yu CH; Chen CH; Tsai TT; Kuo DY
    Neurotoxicology; 2015 May; 48():131-41. PubMed ID: 25825358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional interruption of cAMP response element binding protein modulates superoxide dismutase and neuropeptide Y-mediated feeding behavior in freely moving rats.
    Hsieh YS; Yang SF; Chu SC; Ho YJ; Kuo CS; Kuo DY
    J Neurochem; 2008 May; 105(4):1438-49. PubMed ID: 18221372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrupting activator protein-1 signaling in conscious rats can modify neuropeptide Y gene expression and feeding behavior of phenylpropanolamine.
    Hsieh YS; Yang SF; Chu SC; Kuo DY
    J Neurochem; 2008 Jan; 104(1):50-61. PubMed ID: 17868324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of reactive oxygen species-related enzymes in neuropeptide y and proopiomelanocortin-mediated appetite control: a study using atypical protein kinase C knockdown.
    Kuo DY; Chen PN; Yang SF; Chu SC; Chen CH; Kuo MH; Yu CH; Hsieh YS
    Antioxid Redox Signal; 2011 Oct; 15(8):2147-59. PubMed ID: 21453188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knocking down the transcript of NF-kappaB modulates the reciprocal regulation of endogenous antioxidants and feeding behavior in phenylpropanolamine-treated rats.
    Kuo DY; Chen PN; Chu SC; Hsieh YS
    Arch Toxicol; 2012 Mar; 86(3):453-63. PubMed ID: 21989786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical and genomic evidence for the involvement of hypothalamic neuropeptide Y (NPY) in phenylpropranolamine-mediated appetite suppression.
    Hsieh YS; Hsu JD; Yang SF; Kuo DY
    Peptides; 2004 Dec; 25(12):2155-61. PubMed ID: 15572205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both neuropeptide Y knockdown and Y1 receptor inhibition modulate CART-mediated appetite control.
    Chu SC; Chen PN; Ho YJ; Yu CH; Hsieh YS; Kuo DY
    Horm Behav; 2015 Jan; 67():38-47. PubMed ID: 25461972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting oxidative stress in the hypothalamus: the effect of transcription factor STAT3 knockdown on endogenous antioxidants-mediated appetite control.
    Kuo DY; Chen PN; Hsieh YS
    Arch Toxicol; 2015 Jan; 89(1):87-100. PubMed ID: 24792324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of protein kinase C-delta knockdown on anti-free radical enzyme and neuropeptide Y gene expression in phenylpropanolamine-treated rats.
    Kuo DY; Yang SF; Chu SC; Chen CH; Chen PN; Hsieh YS
    J Neurochem; 2010 Aug; 114(4):1217-30. PubMed ID: 20533995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of central catecholamine and hypothalamic neuropeptide Y genome in the development of tolerance to phenylpropanolamine-mediated appetite suppression.
    Hsieh YS; Yang SF; Chiou HL; Kuo DY
    Behav Neurosci; 2007 Oct; 121(5):933-40. PubMed ID: 17907825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuropeptide Y Y1 receptor knockdown modulates activator protein 1-involved feeding behavior in amphetamine-treated rats.
    Hsieh YS; Chen PN; Yu CH; Liao JM; Kuo DY
    Mol Brain; 2013 Nov; 6():46. PubMed ID: 24225225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of the transcript of ERK in the brain modulates hypothalamic neuropeptide-mediated appetite control in amphetamine-treated rats.
    Yu CH; Hsieh YS; Chen PN; Chen JR; Kuo DY
    Br J Pharmacol; 2018 Feb; 175(4):726-739. PubMed ID: 29215157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.